WOOJUNG BIO Inc Cash Flow Conversion Efficiency

Latest as of March 2026: -0.065x

WOOJUNG BIO Inc cash flow conversion efficiency. Based on the latest financial reports, WOOJUNG BIO Inc (215380) has a cash flow conversion efficiency ratio of -0.065x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.51 Billion ≈ $-1.03 Million USD) by net assets (₩23.17 Billion ≈ $15.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of WOOJUNG BIO Inc (2016–2025)

Cash flow conversion efficiency of WOOJUNG BIO Inc from 2016 to 2025. This chart illustrates how WOOJUNG BIO Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 215380 stock price and chart for real-time trading data and today's change.

WOOJUNG BIO Inc Cash Flow Conversion Ratio Explained

WOOJUNG BIO Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

WOOJUNG BIO Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of WOOJUNG BIO Inc ranked by their cash flow conversion efficiency. Also see WOOJUNG BIO Inc (215380) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Nextplat Corp NASDAQ:NXPL	0.066x
Kidoz Inc V:KIDZ	0.061x
Slj Global Tbk JK:SULI	-0.018x
Filter Vision Public Company Limited BK:FVC	-0.091x
Tekom Technologies TWO:6294	0.034x
First Graphene Ltd F:M11	-0.111x
Quickfee Ltd AU:QFE	-0.564x
Leviathan Gold Ltd V:LVX	-0.032x

Annual Cash Flow Conversion Efficiency for WOOJUNG BIO Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of WOOJUNG BIO Inc from 2016 to 2025. Review 215380 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩23.38 Billion ≈ $15.84 Million	₩-630.50 Million ≈ $-427.28K	-0.027x	+29.67%
2024-12-31	₩29.37 Billion ≈ $19.91 Million	₩-1.13 Billion ≈ $-763.37K	-0.038x	+73.85%
2023-12-31	₩21.97 Billion ≈ $14.89 Million	₩-3.22 Billion ≈ $-2.18 Million	-0.147x	-274.16%
2022-12-31	₩29.72 Billion ≈ $20.14 Million	₩2.50 Billion ≈ $1.70 Million	0.084x	+53.31%
2021-12-31	₩31.46 Billion ≈ $21.32 Million	₩1.73 Billion ≈ $1.17 Million	0.055x	+117.95%
2020-12-31	₩28.03 Billion ≈ $19.00 Million	₩-8.57 Billion ≈ $-5.81 Million	-0.306x	-4007.26%
2019-12-31	₩26.66 Billion ≈ $18.07 Million	₩208.72 Million ≈ $141.45K	0.008x	+134.30%
2018-12-31	₩21.20 Billion ≈ $14.37 Million	₩-483.80 Million ≈ $-327.87K	-0.023x	+82.39%
2017-12-31	₩18.32 Billion ≈ $12.42 Million	₩-2.38 Billion ≈ $-1.61 Million	-0.130x	+5.85%
2016-12-31	₩10.57 Billion ≈ $7.16 Million	₩-1.46 Billion ≈ $-986.04K	-0.138x	--

About WOOJUNG BIO Inc

KQ:215380 Korea Biotechnology

Market Cap

$21.84 Million

₩32.22 Billion KRW

Market Cap Rank

#24669 Global

#1778 in Korea

Share Price

₩1933.00

Change (1 day)

-1.02%

52-Week Range

₩1761.00 - ₩3605.00

All Time High

₩13450.00